116 related articles for article (PubMed ID: 2111678)
21. Nafamstat mesilate attenuates pulmonary hypertension in heparin-protamine reactions.
Kreil E; Montalescot G; Greene E; Fitzgibbon C; Robinson D; Chenoweth D; Zapol WM
J Appl Physiol (1985); 1989 Oct; 67(4):1463-71. PubMed ID: 2793750
[TBL] [Abstract][Full Text] [Related]
22. Effect of leukopenia on pulmonary hypertension after heparin-protamine in pigs.
Habazettl H; Conzen PF; Vollmar B; Yekebas E; Peter K
J Appl Physiol (1985); 1992 Jul; 73(1):44-9. PubMed ID: 1506397
[TBL] [Abstract][Full Text] [Related]
23. Effect of BAY 41-2272 in the pulmonary hypertension induced by heparin-protamine complex in anaesthetized dogs.
Freitas CF; Morganti RP; Annichino-Bizzacchi JM; De Nucci G; Antunes E
Clin Exp Pharmacol Physiol; 2007; 34(1-2):10-4. PubMed ID: 17201729
[TBL] [Abstract][Full Text] [Related]
24. Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction.
Comunale ME; Maslow A; Robertson LK; Haering JM; Mashikian JS; Lowenstein E
J Cardiothorac Vasc Anesth; 2003 Jun; 17(3):309-13. PubMed ID: 12827577
[TBL] [Abstract][Full Text] [Related]
25. Absence of prostaglandin changes associated with protamine administration in patients with pulmonary hypertension.
Konstadt SN; Thys DM; Kong D; Mindich BP; Watkins WD
J Cardiothorac Anesth; 1987 Oct; 1(5):388-91. PubMed ID: 2979108
[TBL] [Abstract][Full Text] [Related]
26. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep.
Fratacci MD; Frostell CG; Chen TY; Wain JC; Robinson DR; Zapol WM
Anesthesiology; 1991 Dec; 75(6):990-9. PubMed ID: 1741521
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular effects of protamine sulfate are dependent on the presence and type of circulating heparin.
Fiser WP; Fewell JE; Hill DE; Barnes RW; Read RC
J Thorac Cardiovasc Surg; 1985 Jan; 89(1):63-70. PubMed ID: 3965817
[TBL] [Abstract][Full Text] [Related]
28. Effects of protamine on nitric oxide level in the pulmonary circulation.
Kalaycioğlu S; Sinci V; Erbaş D
Jpn Heart J; 1999 May; 40(3):335-8. PubMed ID: 10506855
[TBL] [Abstract][Full Text] [Related]
29. Protamine: does it alter right ventricular function?
Hines RL; Barash PG
Anesth Analg; 1986 Dec; 65(12):1271-4. PubMed ID: 3777455
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary hypertensive effect of heparin and protamine interaction: evidence for thromboxane B2 release from the lung.
Degges RD; Foster ME; Dang AQ; Read RC
Am J Surg; 1987 Dec; 154(6):696-9. PubMed ID: 3425821
[TBL] [Abstract][Full Text] [Related]
31. Heparin reversal by protamine in humans--complement, prostaglandins, blood cells, and hemodynamics.
Hobbhahn J; Conzen PF; Habazettl H; Gutmann R; Kellermann W; Peter K
J Appl Physiol (1985); 1991 Oct; 71(4):1415-21. PubMed ID: 1757364
[TBL] [Abstract][Full Text] [Related]
32. Protamine reactions, explosive mediator release, and pulmonary vasoconstriction.
Lowenstein E; Zapol WM
Anesthesiology; 1990 Sep; 73(3):373-5. PubMed ID: 2393123
[No Abstract] [Full Text] [Related]
33. Hydrogen peroxide induced pulmonary vasoconstriction in isolated rat lungs is attenuated by U60,257, a leucotriene synthesis blocker.
Burghuber OC; Strife R; Zirolli J; Mathias MM; Murphy RC; Reeves JT; Voelkel NF
Wien Klin Wochenschr; 1986 Feb; 98(4):117-9. PubMed ID: 3518246
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary hypertension after heparin-protamine: roles of left-sided infusion, histamine, and platelet-activating factor.
Habazettl H; Conzen PF; Vollmar B; Yekebas E; Gutmann R; Hobbhahn J; Brendel W; Peter K
Anesth Analg; 1990 Dec; 71(6):637-44. PubMed ID: 2240637
[TBL] [Abstract][Full Text] [Related]
35. Role of paf-acether in protamine-induced thrombocytopenia in rabbits.
Nathan N; Aissa J; Benveniste J; Arnoux B
Eur J Anaesthesiol; 1992 Jul; 9(4):347-52. PubMed ID: 1628640
[TBL] [Abstract][Full Text] [Related]
36. Effect of a thromboxane synthetase inhibitor on protamine-induced circulatory changes in sheep.
Sugi K; Esato K
Surgery; 1993 Sep; 114(3):586-90. PubMed ID: 8367815
[TBL] [Abstract][Full Text] [Related]
37. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
Stefaniszyn HJ; Novick RJ; Salerno TA
J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
[TBL] [Abstract][Full Text] [Related]
38. Rat pulmonary artery restructuring and pulmonary hypertension induced by continuous Escherichia coli endotoxin infusion.
Kirton OC; Jones R
Lab Invest; 1987 Feb; 56(2):198-210. PubMed ID: 3543489
[TBL] [Abstract][Full Text] [Related]
39. Use of nitric oxide for treatment of pulmonary hypertensive crisis in a child after protamine administration.
Sakhai H; Casta A
J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):719-21. PubMed ID: 17023297
[No Abstract] [Full Text] [Related]
40. Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without adverse effects of heparin-protamine complexes.
Cook JJ; Niewiarowski S; Yan Z; Schaffer L; Lu W; Stewart GJ; Mosser DM; Myers JA; Maione TE
Circulation; 1992 Mar; 85(3):1102-9. PubMed ID: 1537108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
